Eugene Schneider

Chief Tech/Sci/R&D Officer bei IONIS PHARMACEUTICALS, INC.

Vermögen: 2 Mio $ am 31.03.2024

Health Technology

Consumer Services

Health Services

Aktive Positionen von Eugene Schneider

Unternehmen	Position	Beginn	Ende
IONIS PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	-	-
Excellus Health Plan, Inc. Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY.	Chief Tech/Sci/R&D Officer	-	-

Unternehmen	Position	Beginn	Ende
Biovail Technologies Ltd.	Chief Tech/Sci/R&D Officer	-	-
SYNAGEVA BIOPHARMA CORP	Chief Tech/Sci/R&D Officer	-	-

University of Medicine & Dentistry of New Jersey

Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	4
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
IONIS PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	3
Excellus Health Plan, Inc. Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY.	Health Services
Biovail Technologies Ltd.
Synageva BioPharma Corp. Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA.	Health Technology